Delivery Order SPE2DB22D3016-SPE2DB23FAZU9

Award Date 4/28/23
Potential Completion Date 5/1/23
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $971.74 delivery order contract to Amerisourcebergen Drug Corporation for the supply of 10mL bottles of 0.2%-0.5% brimonidine-timolol ophthalmic solution. The contract has a firm fixed price and calls for delivery to a location in Conshohocken, Pennsylvania, with performance periods spanning August 17-18, 2023. No major subcontractors or set aside designations were indicated. The DLA functions to support military readiness by procuring and providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,098.84 firm fixed-price contract, awarded on November 21, 2024, is for the delivery of Brimonidine-Timolol 0.2%-0.5% ophthalmic solution in 10mL bottles. There was no set-aside designation for this open competition contract, which has a completion date of November 22, 2024. Amerisourcebergen...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,439.96 firm fixed-price contract is for the supply of 4566932081 - Brimonidine Tartrate 0.15% Ophthalmic Drops, 10 mL. The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999...
<p>Defense Logistics Agency awarded a $12,157.60 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for brimonidine-timolol 0.2%-0.5% ophthalmic solution. Performance will occur in Conshohocken, Pennsylvania by October 13, 2023. No set-aside designation was used for this contract to supply the requested pharmaceutical product in support of DLA programs.</p>
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,883.20 Firm Fixed Price Delivery Order covers the supply of Brimonidine Tartrate 0.15% eye drops, a medication used to treat glaucoma. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Brimonidine Tartrate 0.15% eye drops in 15mL bottles to the Defense Logistics Agency (DLA). The $1,451.83 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 24, 2021. The contract has an ultimate completion date of September 27, 2021 and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent...
This federal contract award is for the delivery of Brimonidine Tartrate 0.1% eye drops in a 5mL volume. The award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price of $1,170.00 and a completion date of November 7, 2024. The awardee is not subject to any set-aside requirements. This contract is likely part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,330.21 firm fixed-price delivery order is for the supply of Timolol 0.5% gel-solution, a medication used to treat glaucoma and other eye conditions. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,121.53 fixed-price delivery order is for the supply of 5mL bottles of Timolol 0.25% gel-solution, a medication used to treat glaucoma and other eye conditions. The contract has an ultimate completion date of November 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $1,031.10 firm fixed price delivery order is for the supply of Brimonidine-Timolol 0.2%-0.5% 5ml, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that enables AmerisourceBergen Drug Corp to deliver a...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB23FAZU9
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,644.82, is for the provision of Brimonidine-Timolol 0.2%-0.5% ophthalmic solution, a medication used to treat glaucoma. The contract has an ultimate completion date of May 1, 2023 and is a firm fixed-price delivery order. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and has no listed major subcontractors. The DLA, which supports military treatment facilities, veterans' healthcare programs, and other federal medical institutions, is the funding agency for this contract.

Generated 5/9/25, 10:14 AM